Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
Year: 2014
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm5003606
Authors: Sunhee Kang, Ryang Yeo Kim, Min Jung Seo, Saeyeon Lee, Young Mi Kim, Mooyoung Seo, Jeong Jea Seo, Yoonae Ko, Inhee Choi, Jichan Jang, Jiyoun Nam, Seijin Park, Hwankyu Kang, Hyung Jun Kim, Jungjun Kim, Sujin Ahn, Kevin Pethe, Kiyean Nam, Zaesung No, Jaeseung Kim
Institutions: Institut Pasteur Korea, Qurient (South Korea)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2053500348